¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁ¤Çü¿Ü°ú¿¬±¸ÇÐȸ - Ãá°è ½ÉÆ÷Áö¾ö : 2023-06-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑÁ¤Çü¿Ü°ú¿¬±¸ÇÐȸ - Ãá°è ½ÉÆ÷Áö¾ö : 2023-06-03
±³À°ÀÏÀÚ : 2023-06-03
±³À°Àå¼Ò : ¼¼Á¾´ëÇб³ ´ë¾çAIȦ 12Ãþ

±³À°ÁÖÁ¦ : ´ëÇÑÁ¤Çü¿Ü°ú¿¬±¸ÇÐȸ - Ãá°è ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ¿¬±¸ÇÐȸ(º¯°æ 22.9.15 ´ëÇÑÁ¤Çü¿Ü°ú¿¬±¸,»ýü,±âÃÊÇÐȸ)

´ã´çÀÚ : ¹Ú±¤È¯
¿¬¶ôó : 010-9170-7884

À̸ÞÀÏ : khpark800@gmail.com

±³À°Á¾·ù : Á¤Çü¿Ü°ú

Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 15ºÐ

¼¼ºÎ¼ö°­·á : 60,000¿ø  

ºñ°í Á¤È¸¿ø: 60,000¿ø / Çлý, Àü°øÀÇ, ÁØȸ¿ø: 50,000¿ø / ºñȸ¿ø: 70,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 09:00~09:15 ¾çÀÚ¼¾½Ì À̹Ì¡°ú ¹ÙÀÌ¿À ÀÇ·áºÐ¾ß È°¿ë À̵¿Çå(°í·Á´ë ¹°¸®Çаú)

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 09:15~09:30 ¸»ÃʽŰæ Àç»ý ¹× °ñÀç»ýÀ» À§ÇÑ ÀÓÇöõÆ® Àü±âÀڱر⠱¸ÀÚÇö(°í·Á´ë ¹ÙÀÌ¿À°øÇкÎ)

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 09:30~09:50 µðÁöÅÐ Æ®À©ÀÇ ÀÌÇØ¿Í ÀÓ»ó È°¿ë ±ÇÁöÈÆ(¼­¿ï¾Æ»êº´¿ø ÀÇ°øÇבּ¸¼Ò)

Åä·Ð 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 09:50~10:00 Discussion ()

ÈÞ½Ä 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 10:00~10:20 ÈÞ½Ä ()

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 10:20~10:35 ¿Ü°ú Áø´Ü°ú ¼ö¼ú¿¡ È°¿ë°¡´ÉÇÑ ÀΰøÁö´É ±â¼ú ¹Ú»óÇö(DGIST ·Îº¿¹×±â°èÀüÀÚ°øÇаú)

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 10:35~10:50 °ñÀý Á¤º¹ ½Ã¼ú ·Îº¿ÀÇ Áö´ÉÁ¦¾î ¹× ±Ý¼ÓÁ¤ ³»°íÁ¤ ¼ö¼úÀÇ ¿øÀ§ºÎ ü°á ·Îº¿ ½Ã½ºÅÛ °³¹ß °í¼º¿µ(Àü³²´ë ±â°è°ú )

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 10:50~11:10 Á¤Çü¿Ü°ú ¼ö¼ú·Îº¿ °³¹ß Á¤»óÇö(¿¡¾î½º)

Åä·Ð 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 11:10~11:20 Discussion ()

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 11:20~11:35 The mevalonate pathway as a therapeutic target for osteoporosis ±è¼ºÁø(¼­¿ïÄ¡´ë ±¸°­»ý¹°Çб³½Ç)

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 11:35~11:50 The effect of novel RANKL-derived LGR4 agonist for osteoporosis treatment ÀÓ¿øºÀ(Á¶¼±ÀÇ´ë ÀÇ¿¹°ú)

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 11:50~12:10 A novel disease-modifying osteoarthritis drug candidate targeting OSCAR ±èÁöÈñ(ÀÌÈ­¿©´ë »ý¸í°úÇаú)

Åä·Ð 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 12:10~12:20 Discussion ()

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 12:20~13:20 Áᫎ ()

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 13:20~13:40 Role of Runx/Cbfb complex during osteoarthritis ÃÖÁ¦¿ë(°æºÏÀÇ´ë »ýÈ­ÇС¤¼¼Æ÷»ý¹°Çб³½Ç)

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 13:40~14:00 Blockade of activin receptor IIB protects arthritis pathogenesis ¾ç½Ã¿µ(¾ÆÁÖÀÇ´ë ¾à¸®Çб³½Ç)

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 14:00~14:20 Protective effects of cholesterol-lowering drugs on osteoarthritis ·ùÁ¦È²(Àü³²Ä¡´ë Ä¡°ú¾à¸®Çб³½Ç)

Åä·Ð 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 14:20~14:35 Discussion ()

ÈÞ½Ä 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 14:35~14:55 ÈÞ½Ä ()

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 14:55~15:10 Translational research to develop a novel sarcopenia treatment À̱¤Ç¥(Çѱ¹»ý¸í°øÇבּ¸¿ø)

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 15:10~15:25 Sarcopenia: clinical implications in osteoporosis management È«³²±â(¿¬¼¼ÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 15:25~15:45 Development of a machine learning driven novel blood biomarker of sarcopenia ·ùµ¿·Ä(±¤ÁÖ°úÇбâ¼ú¿ø ÀÇ»ý¸í°øÇаú)

Åä·Ð 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 15:45~15:55 Discussion ()

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 15:55~16:10 Exosome researches for musculoskeletal disorders À̱ٿì(¿µ³²ÀÇ´ë Á¤Çü¿Ü°ú)

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 16:10~16:25 FreSHtracer ±â¼ú·Î ¼±º°µÈ °í±â´É¼º ¼ºÃ¼Áٱ⼼Æ÷¸¦ ÀÌ¿ëÇÑ °ñ°üÀý¿° ¼¼Æ÷Ä¡·áÁ¦ °³¹ß ¹Î¼º±â(¼¿ÅõÀÎ)

±³À°½Ã°£ 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 16:25~16:45 ¼Õ»ó ¿¬°ñ¿¡ ´ëÇÑ TGF¥â-3ÀÇ Àç»ý È¿´É ¹× ³óµµ ÀÇÁ¸¼º ÀüÀÓ»ó Æò°¡ À¯¹Ì¿µ(½ÃÁö¹ÙÀÌ¿À)

Åä·Ð 06¿ù 03ÀÏ °­ÀǽÇ(´ë¾ç AIȦ) 16:45~16:55 Discussion ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁ¤Çü¿Ü°ú¿¬±¸ÇÐȸ - Ãá°è ½ÉÆ÷Áö¾ö : 2023-06-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ)ÀÌ´ë¸ñµ¿º´¿ø »êºÎÀΰú Áö¿ªÀÇ»ç °£´ãȸ(Æó°æÈ£¸£¸ó¿ä¹ý) : 2023-06-03
´ÙÀ½±Û ´ëÇѿ°èÁٱ⼼Æ÷Àç»ýÀÇÇÐȸ - Á¦8ȸ Live Surgery Symposium : 2023-06-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 12 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 17 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 9 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 6 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 8 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 11 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 4 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 4 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 3 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 6 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 6 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 4 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 5 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 4 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 7 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷